Literature DB >> 7972956

Sensitivity of physiologically based pharmacokinetic models to variation in model parameters: methylene chloride.

H J Clewell1, T S Lee, R L Carpenter.   

Abstract

The parameters in a physiologically based pharmacokinetic (PBPK) model of methylene chloride were varied systematically, and the resulting variation in a number of model outputs was determined as a function of time for mice and humans at several exposure concentrations. The importance of the various parameters in the model was highly dependent on the conditions (concentration, species) for which the simulation was performed and the model output (dose surrogate) being considered. Model structure also had a significant impact on the results. For sensitivity analysis, particular attention must be paid to conservation equations to ensure that the variational calculations do not alter mass balance, introducing extraneous effects into the model. All of the normalized sensitivity coefficients calculated in this study ranged between -1.12 and 1, and most were much less than 1 in absolute value, indicating that individual input errors are not greatly amplified in the outputs. In addition to ranking parameters in terms of their impact on model predictions, time-dependent sensitivity analysis can also be used as an aid in the design of experiments to estimate parameters by predicting the experimental conditions and sampling points which will maximize parameter identifiability.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972956     DOI: 10.1111/j.1539-6924.1994.tb00268.x

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  15 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Uncertainty analysis in pharmacokinetics and pharmacodynamics: application to naratriptan.

Authors:  Ivelina Gueorguieva; Ivan A Nestorov; Leon Aarons; Malcolm Rowland
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

3.  Reducing whole body physiologically based pharmacokinetic models using global sensitivity analysis: diazepam case study.

Authors:  Ivelina Gueorguieva; Ivan A Nestorov; Malcolm Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-12-20       Impact factor: 2.745

4.  Differential pharmacokinetic analysis of in vivo erythropoietin receptor interaction with erythropoietin and continuous erythropoietin receptor activator in sheep.

Authors:  Mohammed H El-Komy; Robert L Schmidt; John A Widness; Peter Veng-Pedersen
Journal:  Biopharm Drug Dispos       Date:  2011-06-15       Impact factor: 1.627

5.  Estimating Methylmercury Intake for the General Population of South Korea Using Physiologically Based Pharmacokinetic Modeling.

Authors:  Seungho Lee; Yu-Mei Tan; Martin B Phillips; Jon R Sobus; Sungkyoon Kim
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

6.  Inhalation dosimetry modeling with decamethylcyclopentasiloxane in rats and humans.

Authors:  Micaela B Reddy; Ivan D Dobrev; Debra A McNett; Joseph M Tobin; Mark J Utell; Paul E Morrow; Jeanne Y Domoradzki; Kathleen P Plotzke; Melvin E Andersen
Journal:  Toxicol Sci       Date:  2008-06-26       Impact factor: 4.849

7.  Physiologically based pharmacokinetics of matrine in the rat after oral administration of pure chemical and ACAPHA.

Authors:  Guanghua Gao; Francis C P Law
Journal:  Drug Metab Dispos       Date:  2009-01-08       Impact factor: 3.922

8.  A Bayesian population PBPK model for multiroute chloroform exposure.

Authors:  Yuching Yang; Xu Xu; Panos G Georgopoulos
Journal:  J Expo Sci Environ Epidemiol       Date:  2009-05-27       Impact factor: 5.563

9.  PBPK modeling/Monte Carlo simulation of methylene chloride kinetic changes in mice in relation to age and acute, subchronic, and chronic inhalation exposure.

Authors:  R S Thomas; R S Yang; D G Morgan; M P Moorman; H R Kermani; R A Sloane; R W O'Connor; B Adkins; M L Gargas; M E Andersen
Journal:  Environ Health Perspect       Date:  1996-08       Impact factor: 9.031

10.  Development of a physiologically based model to describe the pharmacokinetics of methylphenidate in juvenile and adult humans and nonhuman primates.

Authors:  Xiaoxia Yang; Suzanne M Morris; Jeffery M Gearhart; Christopher D Ruark; Merle G Paule; William Slikker; Donald R Mattison; Benedetto Vitiello; Nathan C Twaddle; Daniel R Doerge; John F Young; Jeffrey W Fisher
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.